Repros Therapeutics Inc. (RPRX) Drops 5.97% on December 25

Equities Staff |

Repros Therapeutics Inc. (RPRX) was one of the Russell 2000's biggest losers for Friday December 25 as the stock slid 5.97% to $1.26, a loss of $-0.08 per share. Starting at an opening price of $1.34 a share, the stock traded between $1.22 and $1.38 over the course of the trading day. Volume was 343,250 shares over 651 trades, against an average daily volume of 744,227 shares and a total float of 24.32 million.

The losses send Repros Therapeutics Inc. down to a market cap of $30.64 million. In the last year, Repros Therapeutics Inc. has traded between $10.55 and $1.09, and its 50-day SMA is currently $2.49 and 200-day SMA is $6.48.

Repros Therapeutics Inc is a development stage biopharmaceutical company. The Company is engaged in the development of new drugs to treat hormonal and reproductive system disorders.

Repros Therapeutics Inc. is based out of The Woodlands, TX and has some 27 employees. Its CEO is Joseph S. Podolski.

For a complete fundamental analysis analysis of Repros Therapeutics Inc., check out Equities.com’s Stock Valuation Analysis report for RPRX. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

Winston Gold Mining Corp.

Winston Gold Mining Corp is a mineral exploration and development company. The Company is engaged in acquiring, exploring, developing, and operating mining properties.

Private Markets

XY Find It

Founded by serial entrepreneur Arie Trouw, XY Findables follows a single guiding principle: customers should never lose anything important again. With over 50,000 users around the world, more than 100,000…

Cross Campus

With over 500 members and operating 80,000 square feet by summer 2016, Cross Campus is one of the country’s top ten shared, collaborative office or "coworking" operators in the US.…